287 related articles for article (PubMed ID: 29331959)
1. Probenecid Improves Cardiac Function in Patients With Heart Failure With Reduced Ejection Fraction In Vivo and Cardiomyocyte Calcium Sensitivity In Vitro.
Robbins N; Gilbert M; Kumar M; McNamara JW; Daly P; Koch SE; Conway G; Effat M; Woo JG; Sadayappan S; Rubinstein J
J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29331959
[TBL] [Abstract][Full Text] [Related]
2. Repurposing Probenecid for the Treatment of Heart Failure (Re-Prosper-HF): a study protocol for a randomized placebo-controlled clinical trial.
Rubinstein J; Robbins N; Evans K; Foster G; Mcconeghy K; Onadeko T; Bunke J; Parent M; Luo X; Joseph J; Wu WC
Trials; 2022 Apr; 23(1):266. PubMed ID: 35392963
[TBL] [Abstract][Full Text] [Related]
3. Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene.
Hillestad V; Kramer F; Golz S; Knorr A; Andersson KB; Christensen G
J Appl Physiol (1985); 2013 Nov; 115(10):1572-80. PubMed ID: 24072410
[TBL] [Abstract][Full Text] [Related]
4. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure).
Wan SH; Stevens SR; Borlaug BA; Anstrom KJ; Deswal A; Felker GM; Givertz MM; Bart BA; Tang WH; Redfield MM; Chen HH
Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27512103
[TBL] [Abstract][Full Text] [Related]
5. Effects of a myofilament calcium sensitizer on left ventricular systolic and diastolic function in rats with volume overload heart failure.
Wilson K; Guggilam A; West TA; Zhang X; Trask AJ; Cismowski MJ; de Tombe P; Sadayappan S; Lucchesi PA
Am J Physiol Heart Circ Physiol; 2014 Dec; 307(11):H1605-17. PubMed ID: 25260618
[TBL] [Abstract][Full Text] [Related]
6. Xanthine oxidase inhibition preserves left ventricular systolic but not diastolic function in cardiac volume overload.
Gladden JD; Zelickson BR; Guichard JL; Ahmed MI; Yancey DM; Ballinger S; Shanmugam M; Babu GJ; Johnson MS; Darley-Usmar V; Dell'Italia LJ
Am J Physiol Heart Circ Physiol; 2013 Nov; 305(10):H1440-50. PubMed ID: 24014679
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial.
Berg-Hansen K; Gopalasingam N; Christensen KH; Ladefoged B; Andersen MJ; Poulsen SH; Borlaug BA; Nielsen R; Møller N; Wiggers H
Circulation; 2024 May; 149(19):1474-1489. PubMed ID: 38533643
[TBL] [Abstract][Full Text] [Related]
8. Extended-Release Oral Milrinone for the Treatment of Heart Failure With Preserved Ejection Fraction.
Nanayakkara S; Byrne M; Mak V; Carter K; Dean E; Kaye DM
J Am Heart Assoc; 2020 Jul; 9(13):e015026. PubMed ID: 32552264
[TBL] [Abstract][Full Text] [Related]
9. Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction.
Connelly KA; Zhang Y; Desjardins JF; Nghiem L; Visram A; Batchu SN; Yerra VG; Kabir G; Thai K; Advani A; Gilbert RE
Cardiovasc Diabetol; 2020 Feb; 19(1):13. PubMed ID: 32035482
[TBL] [Abstract][Full Text] [Related]
10. Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation.
Koch SE; Gao X; Haar L; Jiang M; Lasko VM; Robbins N; Cai W; Brokamp C; Varma P; Tranter M; Liu Y; Ren X; Lorenz JN; Wang HS; Jones WK; Rubinstein J
J Mol Cell Cardiol; 2012 Jul; 53(1):134-44. PubMed ID: 22561103
[TBL] [Abstract][Full Text] [Related]
11. Novel Mitochondria-Targeting Peptide in Heart Failure Treatment: A Randomized, Placebo-Controlled Trial of Elamipretide.
Daubert MA; Yow E; Dunn G; Marchev S; Barnhart H; Douglas PS; O'Connor C; Goldstein S; Udelson JE; Sabbah HN
Circ Heart Fail; 2017 Dec; 10(12):. PubMed ID: 29217757
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older heart failure patients with preserved ejection fraction: study protocol for a randomized controlled trial.
Park K; Park TH
Trials; 2016 Nov; 17(1):530. PubMed ID: 27809882
[TBL] [Abstract][Full Text] [Related]
13. Associations of Empagliflozin With Left Ventricular Volumes, Mass, and Function in Patients With Heart Failure and Reduced Ejection Fraction: A Substudy of the Empire HF Randomized Clinical Trial.
Omar M; Jensen J; Ali M; Frederiksen PH; Kistorp C; Videbæk L; Poulsen MK; Tuxen CD; Möller S; Gustafsson F; Køber L; Schou M; Møller JE
JAMA Cardiol; 2021 Jul; 6(7):836-840. PubMed ID: 33404637
[TBL] [Abstract][Full Text] [Related]
14. Acyl ghrelin improves cardiac function in heart failure and increases fractional shortening in cardiomyocytes without calcium mobilization.
Lund LH; Hage C; Pironti G; Thorvaldsen T; Ljung-Faxén U; Zabarovskaja S; Shahgaldi K; Webb DL; Hellström PM; Andersson DC; Ståhlberg M
Eur Heart J; 2023 Jun; 44(22):2009-2025. PubMed ID: 36916707
[TBL] [Abstract][Full Text] [Related]
15. Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study.
Gierula J; Lowry JE; Paton MF; Cole CA; Byrom R; Koshy AO; Chumun H; Kearney LC; Straw S; Bowen TS; Cubbon RM; Keenan AM; Stocken DD; Kearney MT; Witte KK
Circulation; 2020 May; 141(21):1693-1703. PubMed ID: 32299222
[TBL] [Abstract][Full Text] [Related]
16. Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model.
Koch SE; Tranter M; Robbins N; Luther K; Singh U; Jiang M; Ren X; Tee T; Smith L; Varma P; Jones WK; Rubinstein J
J Cardiovasc Pharmacol Ther; 2013 May; 18(3):280-9. PubMed ID: 23241275
[TBL] [Abstract][Full Text] [Related]
17. Heart Failure With Improved Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival: Results From the Valsartan Heart Failure Trial.
Florea VG; Rector TS; Anand IS; Cohn JN
Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413037
[TBL] [Abstract][Full Text] [Related]
18. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.
Edelmann F; Wachter R; Schmidt AG; Kraigher-Krainer E; Colantonio C; Kamke W; Duvinage A; Stahrenberg R; Durstewitz K; Löffler M; Düngen HD; Tschöpe C; Herrmann-Lingen C; Halle M; Hasenfuss G; Gelbrich G; Pieske B;
JAMA; 2013 Feb; 309(8):781-91. PubMed ID: 23443441
[TBL] [Abstract][Full Text] [Related]
19. Empagliflozin directly improves diastolic function in human heart failure.
Pabel S; Wagner S; Bollenberg H; Bengel P; Kovács Á; Schach C; Tirilomis P; Mustroph J; Renner A; Gummert J; Fischer T; Van Linthout S; Tschöpe C; Streckfuss-Bömeke K; Hasenfuss G; Maier LS; Hamdani N; Sossalla S
Eur J Heart Fail; 2018 Dec; 20(12):1690-1700. PubMed ID: 30328645
[TBL] [Abstract][Full Text] [Related]
20. Nitroxyl (HNO): A novel approach for the acute treatment of heart failure.
Sabbah HN; Tocchetti CG; Wang M; Daya S; Gupta RC; Tunin RS; Mazhari R; Takimoto E; Paolocci N; Cowart D; Colucci WS; Kass DA
Circ Heart Fail; 2013 Nov; 6(6):1250-8. PubMed ID: 24107588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
